Nisa Investment Advisors’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2
| Closed | -$35 | – | 2939 |
|
|
2024
Q1 | $35 | Sell |
2
-1
| -33% | -$18 | ﹤0.01% | 2758 |
|
|
2023
Q4 | $41 | Sell |
3
-29
| -91% | -$396 | ﹤0.01% | 2634 |
|
|
2023
Q3 | $1.19K | Buy |
32
+3
| +10% | +$111 | ﹤0.01% | 2372 |
|
|
2023
Q2 | $1.16K | Sell |
29
-29
| -50% | -$1.16K | ﹤0.01% | 2418 |
|
|
2023
Q1 | $4K | Sell |
58
-116
| -67% | -$8K | ﹤0.01% | 2253 |
|
|
2022
Q4 | $14K | Sell |
174
-84
| -33% | -$6.76K | ﹤0.01% | 2129 |
|
|
2022
Q3 | $28K | Buy |
258
+232
| +892% | +$25.2K | ﹤0.01% | 1950 |
|
|
2022
Q2 | $5K | Hold |
26
| – | – | ﹤0.01% | 2266 |
|
|
2022
Q1 | $6K | Buy |
+26
| New | +$6K | ﹤0.01% | 2277 |
|
|
2021
Q4 | – | Sell |
-185
| Closed | -$83 | – | 2209 |
|
|
2021
Q3 | $83 | Hold |
185
| – | – | ﹤0.01% | 1780 |
|
|
2021
Q2 | $72 | Hold |
185
| – | – | ﹤0.01% | 1833 |
|
|
2021
Q1 | $66 | Hold |
185
| – | – | ﹤0.01% | 1921 |
|
|
2020
Q4 | $91K | Buy |
185
+158
| +585% | +$77.7K | ﹤0.01% | 1770 |
|
|
2020
Q3 | $9K | Buy |
27
+10
| +59% | +$3.33K | ﹤0.01% | 2128 |
|
|
2020
Q2 | $6K | Hold |
17
| – | – | ﹤0.01% | 1990 |
|
|
2020
Q1 | $4K | Buy |
17
+8
| +89% | +$1.88K | ﹤0.01% | 1967 |
|
|
2019
Q4 | $4K | Hold |
9
| – | – | ﹤0.01% | 1941 |
|
|
2019
Q3 | $3K | Hold |
9
| – | – | ﹤0.01% | 1950 |
|
|
2019
Q2 | $5K | Hold |
9
| – | – | ﹤0.01% | 1888 |
|
|
2019
Q1 | $9K | Hold |
9
| – | – | ﹤0.01% | 1774 |
|
|
2018
Q4 | $8K | Hold |
9
| – | – | ﹤0.01% | 1691 |
|
|
2018
Q3 | $10K | Buy |
+9
| New | +$10K | ﹤0.01% | 1719 |
|